Literature DB >> 28958968

A major procalcitonin elevation without sepsis in a metastatic small cell lung carcinoma.

Pierre-Alain Billy1, Laurence Parmeland1, Sylvie Brunette2, Sophie Lecordier2, Matthieu Pecquet1.   

Abstract

We report the case of a 54-year-old man with metastatic pulmonary neuroendocrine tumor associated with major procalcitonin (PCT) elevation without sepsis. Three lines of antibiotic therapies were successively introduced but had no positive effect on PCT kinetic and disease progression. Under palliative care, increasing of PCT level was constant during the hospitalization, along with major asthenia and pain and metastatic progression. PCT is an excellent biological marker of bacterial infection, both sensitive and specific. Nevertheless, we highlight here the existence of a frequent association between neuroendocrine tumors and elevation of PCT in the absence of sepsis.

Entities:  

Keywords:  inflammation; neoplasm metastasis; procalcitonin; pulmonary neuroendocrine tumor; tumor

Mesh:

Substances:

Year:  2017        PMID: 28958968     DOI: 10.1684/abc.2017.1281

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  3 in total

1.  Immunohistochemical detection of procalcitonin in fibrolamellar hepatocellular carcinoma.

Authors:  Kotaro Matsumoto; Kentaro Kikuchi; Ayako Hara; Hiromichi Tsunashima; Koichi Tsuneyama; Shinpei Doi
Journal:  Clin J Gastroenterol       Date:  2021-02-10

2.  Procalcitonin expression in patients with large cell neuroendocrine carcinoma of the lung.

Authors:  Masamichi Itoga; Hisashi Tanaka; Kageaki Taima; Yoshiko Ishioka; Hiroaki Sakamoto; Shingo Takanashi; Akira Kurose; Sadatomo Tasaka
Journal:  BMC Res Notes       Date:  2021-01-15

Review 3.  Elevated procalcitonin levels in primary hepatic neuroendocrine carcinoma: Case report and literature review.

Authors:  Xiangjun Han; Hongshan Zhong; Duo Hong; Chenguang Li; Hongying Su; Ke Xu
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.